Document is current
Any future updates will be listed below
-
Authors
Laughlin, Maren
McIndoe, Richard
Adams, Sean H.
Araiza, Renee
Ayala, Julio E.
Kennedy, Lucy
Lanoue, Louise
Lantier, Louise
Macy, James
Malabanan, Eann
McGuinness, Owen P.
Perry, Rachel
Port, Daniel
Qi, Nathan
Elias, Carol F.
Shulman, Gerald I.
Wasserman, David H.
Lloyd, K. C. Kent
-
Funding
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (U24DK135044, U2CDK135074, U2CDK135074, U2CDK135073, U2CDK134901, U2CDK135074, U2CDK135073, U2CDK134901, U2CDK135073, U2CDK135073, U2CDK134901, U2CDK135074, U2CDK135066, U2CDK135066, U2CDK134901, U2CDK135073, U2CDK135074)
- License Information
-
More Information
Article History
Received: 2 July 2024
Accepted: 14 August 2024
First Online: 27 August 2024
Declarations
:
: S.H. Adams is founder and principal of XenoMed, LLC, which is focused on research and discovery in the area of microbial metabolism. XenoMed had no part in the research design, funding, or writing of the manuscript.
